Kwality Pharmaceuticals receives SFDA GMP approval for 2 units

This certification will open new markets for the Kwality Pharma

Kwality Pharmaceuticals receives approval for Tamoxifen 20mg Tablet in South Africa

This approval is a significant achievement in expanding the availability of this critical therapeutic,

Kwality Pharmaceuticals receives DIGIMED approval for generic, injectable and OSD

Kwality Pharma already has registration of 20 molecules from the units and 20 are under registration

Kwality Pharmaceuticals receives approval from INVIMA for Ampoule and Vial product lines

Approval from Colombia's INVIMA will accelerate growth in Colombia, by registering our product and getting regular supplies

Kwality Pharmaceuticals Q1FY23 profit at Rs. 10.52 Cr

The company has reported total income of Rs. 70.59 crores during the period ended June 30, 2022.

Kwality Pharmaceuticals Q4FY21 consolidated PAT higher at Rs. 8.14 Cr

The company reported total income of Rs.263.60 crores during the 12 months period ended March 31, 2021

Kwality Pharma received approval for Leuprorelin Acetate for injectable suspension from Greece